Dr. T Scott Jennings explains that HRT or Hormone Replacement Therapy can be confusing because there are different indications for everyone.
Read the full transcript »
You know hormonal replacement therapy is a confusing topic because there are two basic types and different indications for everybody. In general, hormonal replacement therapy is an issue using medications to prevent the symptoms of menopause essentially and they can be done and two groups of women who want us the group of women who’ve had hysterectomy before and those who’ve none had hysterectomy before. If you look at a woman who’d had no hysterectomy so normal anything going throughout on natural menopause, hormone replacement therapy needs to include early two medications. One is a surgeon which is well on a positive benefits of reducing symptoms but all the negative interferences as breast cancer and as well as the different strokes and heart attacks things like that but there’s also the medications and also called progesterone but the confusing topic is in a woman who require hormone replacement therapy they do have a more risk related that they you’ve to that and that regimen and it’s known that within a couple of years of the initiation of hormone replacement therapy the risk of breast cancer fully increases that increase in hysterectomy as much as 30% even high as 50% and it’s like in studies. It’s been proven in a better league again the WHI studies that can mange in 2002 or very clearly once again demonstrated that breast cancer is an unexpected phenomena for a certain percentage of women I use hormonal placement therapy, It can be already that the numbers of women who actually get breast cancer from hormones is low but it’s a real concern. There’s also the concern with the risk of both clustered legs and the lungs and the risk is not high but it’s always more likely with the hormones than not and as well as the less in strokes and heart attacks in older women who is has having hormones. There are types of hormone replacement therapy is really should be called and associate replacement therapy and this is as usual and it is used by itself and a woman who have had their uterus removed who have had hysterectomy and those woman had the risk for some reason because it’s just association by itself that the risk of breast cancer is not merely as high. Now there are still some slightly increased for us but it’s not merely as predominant as it is but the woman will use and progesterone together so when you think about using hormone replacement therapy or hormone therapy it is really important to identify whether you’re looking at the use of two medications or one and whether you have it you or sort in place or not I’ve had a uterus in place and you will need to consider you use a operation and does have some clear but low degree of risk. A hormonal replacement therapy and breast cancer has been a very hot topic now for over 30 years and it’s been a well established since the 1970’s at least in the laboratory that I associations have some impact on the role of causing breast cancer, The studies that I’ve been out there have been very confusing there are very wide ranging degree of accuracy most recent studies in the last ten years and some consistent and increase and I keep there is breast cancer the interpretation of those studies is always a big issue because there are some many people involved in the use of hormones today and I think it’s a little bit confusing when you look at how you interpret this studies. Many physicians would argue that because the numbers are relatively low on a year to year fashion that the benefits of hormones are worthily low risk of what most people considered be treatable breast cancer, others have let’s just say that any breast cancer issue can and let is call is by hormonal replacement therapy and is really un acceptable so it’s a different in understanding that the numbers on the risk, the studies really do demonstrate that the risk of hormonal replacement therapy are not high but they develop a little time over a period of two or five years there’s risk on our measurable and real and it’s a